Basic AD therapy is based on the use of acetylcholinesterase (AChE) inhibitors (donepezil, galantamine, rivastigmine) and N-methyl-D-aspartate (NMDA) receptor antagonist (memantine) [4,5]. The gene discussed is ACHE; the disease is Alzheimer disease.